Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Lucie Andres Cerezo"'
Autor:
Lucie Andres Cerezo, Adéla Navrátilová, Hana Hulejová, Markéta Pavlíková, Jakub Závada, Karel Pavelka, Ladislav Šenolt, Blanka Stiburkova
Publikováno v:
Arthritis Research & Therapy, Vol 25, Iss 1, Pp 1-7 (2023)
Abstract Objectives IL-37 is an anti-inflammatory cytokine involved in inflammatory and autoimmune diseases. We aimed to investigate the association between IL-37 genetic variants, IL-37 plasma levels, and various clinical phases of gout. Methods The
Externí odkaz:
https://doaj.org/article/0b397d3ce9954805b5cac16c05b19922
Autor:
Lucie Andres, Cerezo, Barbora, Šumová, Hana, Hulejová, Hana, Štorkánová, Lenka, Szczuková, Michal, Tomčík, Radim, Bečvář, Karel, Pavelka, Jiří, Vencovský, Jakub, Závada, Ladislav, Šenolt
Publikováno v:
Clinical and experimental rheumatology. 37(2)
Autor:
Karel Pavelka, Michal Tomčík, Ladislav Šenolt, Jiri Vencovsky, Jakub Zavada, Herman Mann, Olga Šléglová, Olga Růžičková, Hana Hulejová, Lucie Andrés Cerezo, Adéla Navrátilová, Viktor Bečvář, Lucie Štolová
Publikováno v:
RMD Open, Vol 9, Iss 2 (2023)
Objective Interleukin (IL)-40 is a new cytokine related to immune system function and malignancies. Recently, an association of IL-40 with rheumatoid arthritis (RA) and externalisation of neutrophil extracellular traps (NETosis) was found. As neutrop
Externí odkaz:
https://doaj.org/article/372a0b12cd9b42f2a35fc7052e971e4a
Autor:
Adéla Navrátilová, Viktor Bečvář, Jiří Baloun, Dres Damgaard, Claus Henrik Nielsen, David Veigl, Karel Pavelka, Jiří Vencovský, Ladislav Šenolt, Lucie Andrés Cerezo
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
Abstract S100A11 (calgizzarin), a member of S100 family, is associated with several autoimmune diseases, including rheumatoid arthritis (RA). Neutrophil extracellular traps (NETs) are implicated in the pathogenesis of RA and in the externalization of
Externí odkaz:
https://doaj.org/article/c104c105a63f43e199fcdc8d9122af45
Autor:
Barbora Šumová, Lucie Andrés Cerezo, Hana Hulejová, Klára Prajzlerová, Michal Tomčík, Kristýna Bubová, Jan Štěpán, Mária Filková, Tereza Kropáčková, Mariam Grigorian, Karel Pavelka, Jiří Vencovský, Ladislav Šenolt
Publikováno v:
BMC Rheumatology, Vol 4, Iss 1, Pp 1-6 (2020)
Abstract Background S100A4 is a member of calcium binding S100 protein family well known for its role in cancer progression and metastasis. Nevertheless, S100A4 also serves as a negative regulator of bone formation. Dickkopf-1 (DKK-1), marker of bone
Externí odkaz:
https://doaj.org/article/de9c3032994b4b508c4c56f88d58aefe
Autor:
Adela Navrátilová, Lucie Andrés Cerezo, Hana Hulejová, Viktor Bečvář, Michal Tomčík, Martin Komarc, David Veigl, Dana Tegzová, Jakub Závada, Marta Olejárová, Karel Pavelka, Jiří Vencovský, Ladislav Šenolt
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
BackgroundInterleukin 40 (IL-40) is a newly identified B cell-associated cytokine implicated in humoral immune responses and B cell homeostasis. As B cells play a pivotal role in autoimmunity, we investigated the function of IL-40 in rheumatoid arthr
Externí odkaz:
https://doaj.org/article/897554b968044773b38c65bc7efe3f6c
Autor:
Lucie Andrés Cerezo, Barbora Šumová, Klára Prajzlerová, David Veigl, Dres Damgaard, Claus Henrik Nielsen, Karel Pavelka, Jiří Vencovský, Ladislav Šenolt
Publikováno v:
Arthritis Research & Therapy, Vol 19, Iss 1, Pp 1-10 (2017)
Abstract Background Calgizzarin (S100A11) is a member of the S100 protein family that acts in different tumors by regulating a number of biologic functions. Recent data suggest its association with low-grade inflammation in osteoarthritis (OA). The a
Externí odkaz:
https://doaj.org/article/b38982b3128a43f7945dcf2b1b2a2ac8
Autor:
Imogen J. Swift, Rosa Rademakers, NiCole Finch, Matt Baker, Roberta Ghidoni, Luisa Benussi, Giuliano Binetti, Giacomina Rossi, Matthis Synofzik, Carlo Wilke, David Mengel, Caroline Graff, Leonel T. Takada, Raquel Sánchez-Valle, Anna Antonell, Daniela Galimberti, Chiara Fenoglio, Maria Serpente, Marina Arcaro, Stefanie Schreiber, Stefan Vielhaber, Philipp Arndt, Isabel Santana, Maria Rosario Almeida, Fermín Moreno, Myriam Barandiaran, Alazne Gabilondo, Johannes Stubert, Estrella Gómez-Tortosa, Pablo Agüero, M. José Sainz, Tomohito Gohda, Maki Murakoshi, Nozomu Kamei, Sarah Kittel-Schneider, Andreas Reif, Johannes Weigl, Jinlong Jian, Chuanju Liu, Ginette Serrero, Thomas Greither, Gerit Theil, Ebba Lohmann, Stefano Gazzina, Silvia Bagnoli, Giovanni Coppola, Amalia Bruni, Mirja Quante, Wieland Kiess, Andreas Hiemisch, Anne Jurkutat, Matthew S. Block, Aaron M. Carlson, Geir Bråthen, Sigrid Botne Sando, Gøril Rolfseng Grøntvedt, Camilla Lauridsen, Amanda Heslegrave, Carolin Heller, Emily Abel, Alba Gómez-Núñez, Roger Puey, Andrea Arighi, Enmanuela Rotondo, Lize C. Jiskoot, Lieke H. H. Meeter, João Durães, Marisa Lima, Miguel Tábuas-Pereira, João Lemos, Bradley Boeve, Ronald C. Petersen, Dennis W. Dickson, Neill R. Graff-Radford, Isabelle LeBer, Leila Sellami, Foudil Lamari, Fabienne Clot, Barbara Borroni, Valentina Cantoni, Jasmine Rivolta, Alberto Lleó, Juan Fortea, Daniel Alcolea, Ignacio Illán-Gala, Lucie Andres-Cerezo, Philip Van Damme, Jordi Clarimon, Petra Steinacker, Emily Feneberg, Markus Otto, Emma L. van der Ende, John C. van Swieten, Harro Seelaar, Henrik Zetterberg, Aitana Sogorb-Esteve, Jonathan D. Rohrer
Publikováno v:
Alzheimer’s Research & Therapy, Vol 16, Iss 1, Pp 1-13 (2024)
Abstract Background Pathogenic heterozygous mutations in the progranulin gene (GRN) are a key cause of frontotemporal dementia (FTD), leading to significantly reduced biofluid concentrations of the progranulin protein (PGRN). This has led to a number
Externí odkaz:
https://doaj.org/article/1d7c751ac55c494a90e49ef788756561
Autor:
Lucie Andrés Cerezo, Markéta Kuklová, Hana Hulejová, Zdeňka Vernerová, Nikola Kaspříková, David Veigl, Karel Pavelka, Jiří Vencovský, Ladislav Šenolt
Publikováno v:
Mediators of Inflammation, Vol 2015 (2015)
Objective. Progranulin (PGRN) is implicated in the pathogenesis of rheumatoid arthritis (RA). The aim of this study was to assess the relationship between PGRN and disease activity in RA. Methods. PGRN levels were evaluated in patients with RA (n=47)
Externí odkaz:
https://doaj.org/article/f44dd494df9f449b9ffb08f22b72deb1
Autor:
Lucie Andres Cerezo, Hulejova, Hana, Vernerova, Zdenka, Kuklova, Marketa, Pecha, Ondrej, Pesakova, Vlasta, Pavelka, Karel, Vencovsky, Jiri, Senolt, Ladislav
Publikováno v:
ResearcherID
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::326e33255f1a00b1e7fb7d1aec270950
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000297621502203&KeyUID=WOS:000297621502203
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000297621502203&KeyUID=WOS:000297621502203